About Bavarian Nordic Bavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines.

This story revisits the decades-long enigma of hepatitis—once a silent, misunderstood killer—tracing its medical ...

Bavarian Nordic A/S (OMX: BAVA) announced today that Health Canada has accepted for review the Company’s application for licensure of the single-dose, virus-like particle (VLP) chikungunya vaccine ...

The FDA has approved a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

Summary article featuring the latest breakthroughs in vaccine research. Featured stories include the production of a vaccine ...

Prefilled syringe eliminates the need to reconstitute separate vials prior to administration and simplifies the vaccine process.

COPENHAGEN, Denmark, July 9, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced the award of a contract valued over DKK 200 million to supply its MVA-BN ® smallpox/mpox vaccine to a ...

The smallpox vaccine caused scars due to the body’s healing process. The vaccine itself was delivered in a rather different way to many other vaccines given today, using a special two-pronged ...

TNX-801 is up to 100,000-fold less virulent than live smallpox vaccine strains and a single dose provides robust immunogenicity and protection against mpox and rabbitpox (more than one year) in ...

Prefilled syringe eliminates the need to reconstitute separate vials prior to administration and simplifies the vaccine process.

Originally developed as a smallpox vaccine in collaboration with the U.S. government to ensure the supply of a smallpox vaccine for the entire population, including immunocompromised individuals ...

Originally developed as a smallpox vaccine in collaboration with the U.S. government to ensure the supply of a smallpox vaccine for the entire population, including immunocompromised individuals ...